Literature DB >> 18425363

Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.

Hironobu Hata1, Tetsuya Kitamura, Fumihiro Higashino, Kyoko Hida, Koichi Yoshida, Yoichi Ohiro, Yasunori Totsuka, Yoshimasa Kitagawa, Masanobu Shindoh.   

Abstract

Matrix metalloproteinase (MMP) is closely involved in the degradation of extracellular matrix and confers invasive and metastatic potential to malignant tumors. MMP-2 is a type-IV collagenase secreted as a proenzyme that is activated on the surface of the tumor cell by membrane-type 1-MMP (MT1-MMP). MT1-MMP plays a critical role during tumor progression and metastasis. We investigated the expression levels of E1AF and MT1-MMP in malignant melanoma cell lines and specimens from patients in order to clarify the mechanisms responsible for the invasion and metastasis of malignant melanoma. High levels of E1AF and MT1-MMP mRNA expression were observed in melanoma cells by Northern blotting and real-time PCR. The expression level was highly correlated with an invasive potential determined by an in vitro invasion assay. The down-regulation of MT1-MMP was identified when E1AF was knocked down by RNA interference. These results suggest that E1AF plays a crucial role in the invasion and metastasis of malignant melanoma through up-regulating the MT1-MMP expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425363

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.

Authors:  Peter C Hollenhorst; Litty Paul; Mary W Ferris; Barbara J Graves
Journal:  Genes Cancer       Date:  2011-01-01

2.  Comprehensive Analysis of ETS Family Members in Melanoma by Fluorescence In Situ Hybridization Reveals Recurrent ETV1 Amplification.

Authors:  Rohit Mehra; Saravana M Dhanasekaran; Nallasivam Palanisamy; Pankaj Vats; Xuhong Cao; Jung H Kim; David Sl Kim; Timothy Johnson; Douglas R Fullen; Arul M Chinnaiyan
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

3.  Targeting Pan-ETS Factors Inhibits Melanoma Progression.

Authors:  Lee Huang; Yougang Zhai; Jennifer La; Jason W Lui; Stephen P G Moore; Elizabeth C Little; Sixia Xiao; Adil J Haresi; Candice Brem; Jag Bhawan; Deborah Lang
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 13.312

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.